Hims & Hers Health Aktie
WKN DE: A2QMYY / ISIN: US4330001060
|
30.07.2026 23:29:13
|
FTC Sues Hims & Hers Over Alleged Privacy And Billing Violation
(RTTNews) - Hims & Hers Health, Inc. (HIMS) is being sued by the U.S. Federal Trade Commission (FTC), along with Los Angeles County and the state of Utah. Regulators allege the telehealth company shared users' sensitive health information with online advertising platforms and used deceptive billing and subscription tactics.
The complaint says Hims & Hers shared customer health data with advertising companies including Meta Platforms and Snap even though it told users their information would stay private. The FTC also claims the company charged customers for prescriptions before they spoke with a healthcare provider and made subscription cancellations harder than necessary.
Hims & Hers denies the allegations, calling them baseless and saying the lawsuit overlooks evidence it submitted during the FTC's nearly three-year investigation. The company says it will fight the case and argues it's meant to grab headlines rather than protect consumers.
The lawsuit is a major escalation in scrutiny of Hims & Hers, one of the largest telehealth providers. The company offers treatments for weight loss, mental health, hair loss, and erectile dysfunction through online consultations and home delivery of prescription medications.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Hims & Hers Health
|
09.02.26 |
MARKT USA/Kleinere Gewinnmitnahmen an Wall Street erwartet (Dow Jones) | |
|
05.02.26 |
Novo Nordisk-Aktie tiefrot: Konkurrenzprodukt von Hims & Hers Health - Auch Eli Lilly-Aktie unter Druck (finanzen.at) |
Analysen zu Hims & Hers Health
Aktien in diesem Artikel
| Hims & Hers Health | 24,06 | 0,17% |
|